SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,352,386 | -49.0% | 1,151,425 | -9.7% | 0.00% | -50.0% |
| Q2 2023 | $8,538,855 | +525691.6% | 1,274,456 | +411.0% | 0.00% | +300.0% |
| Q1 2023 | $1,624 | +501.5% | 249,412 | +686.8% | 0.00% | – |
| Q4 2022 | $270 | -100.0% | 31,701 | -90.9% | 0.00% | -100.0% |
| Q3 2022 | $1,844,000 | -4.4% | 349,280 | -23.2% | 0.00% | 0.0% |
| Q2 2022 | $1,929,000 | -51.3% | 455,051 | -23.6% | 0.00% | -50.0% |
| Q4 2021 | $3,964,000 | -58.4% | 595,259 | -37.6% | 0.00% | -66.7% |
| Q3 2021 | $9,518,000 | +3311.5% | 953,691 | +10461.4% | 0.01% | – |
| Q2 2021 | $279,000 | -82.6% | 9,030 | -75.4% | 0.00% | -100.0% |
| Q1 2021 | $1,603,000 | -79.2% | 36,752 | -77.9% | 0.00% | -83.3% |
| Q4 2020 | $7,694,000 | – | 166,039 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $26,123,999 | 9.73% |
| Nextech Invest Ltd. | 1,910,029 | $12,434,289 | 5.19% |
| K2 PRINCIPAL FUND, L.P. | 2,686,490 | $17,489,051 | 2.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $72,117,305 | 1.61% |
| Orbimed Advisors | 8,740,887 | $56,903,174 | 1.12% |
| SECTORAL ASSET MANAGEMENT INC | 793,587 | $5,166,251 | 0.99% |
| Tejara Capital Ltd | 207,555 | $1,351,183 | 0.69% |
| Rubric Capital Management LP | 3,480,712 | $22,659,435 | 0.59% |
| Resolute Capital Asset Partners LLC | 120,000 | $781 | 0.57% |
| RA Capital Management | 3,009,678 | $19,593,004 | 0.44% |